Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Health
Related: About this forumJury says J&J must pay $8 billion in case over male breast growth linked to Risperdal
Source: Reuters
BUSINESS NEWS OCTOBER 8, 2019 / 5:51 PM / UPDATED AN HOUR AGO
Jury says J&J must pay $8 billion in case over male breast growth linked to Risperdal
Brendan Pierson, Nate Raymond
4 MIN READ
NEW YORK (Reuters) - Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.
The Philadelphia Court of Common Pleas jurys verdict in favor of Nicholas Murray came in the first case in which a Pennsylvania jury had been able to consider awarding punitive damages in one of thousands of Risperdal cases pending in the state.
This jury, as have other juries in other litigations, once again imposed punitive damages on a corporation that valued profits over safety and profits over patients, Murrays lawyers, Tom Kline and Jason Itkin, said in a joint statement. Johnson & Johnson and (subsidiary) Janssen chose billions over children.
J&J said the award was grossly disproportionate with the initial compensatory award in this case, and the company is confident it will be overturned. It added that the jury in the case had not been allowed to hear evidence of Risperdals benefits.
-snip-
Jury says J&J must pay $8 billion in case over male breast growth linked to Risperdal
Brendan Pierson, Nate Raymond
4 MIN READ
NEW YORK (Reuters) - Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.
The Philadelphia Court of Common Pleas jurys verdict in favor of Nicholas Murray came in the first case in which a Pennsylvania jury had been able to consider awarding punitive damages in one of thousands of Risperdal cases pending in the state.
This jury, as have other juries in other litigations, once again imposed punitive damages on a corporation that valued profits over safety and profits over patients, Murrays lawyers, Tom Kline and Jason Itkin, said in a joint statement. Johnson & Johnson and (subsidiary) Janssen chose billions over children.
J&J said the award was grossly disproportionate with the initial compensatory award in this case, and the company is confident it will be overturned. It added that the jury in the case had not been allowed to hear evidence of Risperdals benefits.
-snip-
Read more: https://www.reuters.com/article/us-johnson-johnson-risperdal-verdict/jury-says-jj-must-pay-8-billion-in-case-over-male-breast-growth-linked-to-risperdal-idUSKBN1WN2HK
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
2 replies, 1219 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (1)
ReplyReply to this post
2 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Jury says J&J must pay $8 billion in case over male breast growth linked to Risperdal (Original Post)
Eugene
Oct 2019
OP
mr_lebowski
(33,643 posts)1. Good. Throw the friggin' book at 'em. Read this Rolling Stone article
that I read back when it came out, and you'll see why I feel this way:
https://www.rollingstone.com/politics/politics-news/from-the-issue-bitter-pill-74281/
Risperdal is another drug from the same class of atypical anti-psychotics as the one described in the article that has been massively prescribed for off-label uses.
These drugs were the 'replacement' for Big Pharma's lost profits once the SSRI's went off-patent.
CountAllVotes
(21,075 posts)2. A friend of mine was given this for muscle spams/anxiety
I do not believe it helped her.
And yes, ...
They are so damned greedy!